RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Comparative effectiveness research (CER) is all the rage in the United States right now. It seems that everywhere you turn a conference or meeting or briefing on CER is being conducted. I knew it had got ridiculous when I saw an advertisement (and a website) for an upcoming "national summit" on CER sponsored by a for-profit medical conference company, "featuring a comparative effectiveness boot camp." (Let’s see now, calculating quality adjusted life years while wearing olive drab fatigues?) I am not making this up. The term "comparative effectiveness research" seems to be a relatively recent US coinage, but the concept has been around for ever. It is usually called technology assessment. The idea is to figure out which drug, device, treatment, or diagnostic test works best for a given condition in a given population.